Latest News

Targeted Alpha Therapy as a cancer treatment in clinical trials as a oncology therapies targeting malignant tumors with radioactive particles destroying cells | Image Credit: ©freshidea -stock.adobe.com
Why Radiopharmaceuticals Are Ideal for Treating Cancer

October 16th 2025

Michael Ritchie, chief commercial officer at Champions Oncology, explains what makes radiopharmaceuticals unique in the treatment of cancer.

Drug target identification and lead optimization of hit compound candidates for orphan diseases | Image Credit: © HYUNGKEUN -stock.adobe.com
The Push for Momentum, Not Mistakes in Orphan Drug Development

October 15th 2025

Landkarte *** Europa | Image credit: ©beugdesign - Stock.adobe.com
European Union Life Science Strategy

October 14th 2025

AstraZeneca sign and logo on British-Swedish multinational pharmaceutical and biopharmaceutical company campus - South San Francisco, California, USA - 2020 | Image Credit: © MichaelVi - stock.adobe.com
AstraZeneca’s Cancer Care Contributions to be Highlighted with Trial Data at ESMO Congress

October 13th 2025

High Angle Shot of a Working Desk of an Successful Person in Office with Cityscape Window View. | Image credit: © Gorodenkoff - stock.adobe.com
From Discovery to Delivery: Evolving Practices in Pharma

October 12th 2025

Research into Cold Cancers Heating Up

Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.

Research into Cold Cancers Heating Up; Image: catalin - Stock.adobe.com

More News

© 2025 MJH Life Sciences

All rights reserved.